Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jamie Greenfield"'
Autor:
Kirsten M. Fiest, Jamie Greenfield, Luanne M. Metz, Scott B. Patten, Nathalie Jetté, Ruth Ann Marrie
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background Though many people with multiple sclerosis (MS) have comorbidities, the use of generic and disease-specific health related quality of life (HRQOL) scales to discriminate the effects of comorbidity has not been established. The uti
Externí odkaz:
https://doaj.org/article/4989d7daeabb492c9385d0ed5db28732
Autor:
Simon Zhornitsky, Jamie Greenfield, Marcus W Koch, Scott B Patten, Colleen Harris, Winona Wall, Katayoun Alikhani, Jodie Burton, Kevin Busche, Fiona Costello, Jeptha W Davenport, Scott E Jarvis, Dina Lavarato, Helene Parpal, David G Patry, Michael Yeung, Luanne M Metz
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123824 (2015)
Disease modifying therapies (DMTs) reduce the frequency of relapses and accumulation of disability in multiple sclerosis (MS). Long-term persistence with treatment is important to optimize treatment benefit. This long-term, cohort study was conducted
Externí odkaz:
https://doaj.org/article/3f8c8f700f5941a9a09e95a96507aed5
Autor:
Carlos Camara-Lemarroy, Luanne Metz, Jens Kuhle, David Leppert, Eline Willemse, David KB Li, Anthony Traboulsee, Jamie Greenfield, Graziela Cerchiaro, Claudia Silva, V Wee Yong
Publikováno v:
Camara-Lemarroy, C, Metz, L, Kuhle, J, Leppert, D, Willemse, E, Li, D K B, Traboulsee, A, Greenfield, J, Cerchiaro, G, Silva, C & Yong, V W 2022, ' Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels ', Multiple Sclerosis Journal, vol. 28, no. 13, pp. 2081-2089 . https://doi.org/10.1177/13524585221109761
Multiple Sclerosis Journal, 28(13), 2081-2089. SAGE Publications Ltd
Multiple Sclerosis Journal, 28(13), 2081-2089. SAGE Publications Ltd
Background: In the trial of Minocycline in Clinically Isolated Syndrome (MinoCIS), minocycline significantly reduced the risk of conversion to clinically definite multiple sclerosis (CDMS). Neurofilament light chain (NfL) and glial fibrillary acidic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f238d4df8c5f2f4d67201f642939ae9
https://research.vumc.nl/en/publications/3fc0f334-f7ae-4152-8b84-d77f850d60df
https://research.vumc.nl/en/publications/3fc0f334-f7ae-4152-8b84-d77f850d60df
Publikováno v:
Multiple Sclerosis and Related Disorders. 74:104699
Autor:
James Lee, Guojun Zhao, Irene M. Vavasour, Anthony Trablousee, G. R. Wayne Moore, Luanne M. Metz, David K.B. Li, Roger Tam, Cornelia Laule, Jamie Greenfield, R Davis Holmes
Publikováno v:
Journal of Neuroimaging. 31:981-994
Background and purpose While diffusely abnormal white matter (DAWM) is a nonlesional MRI abnormality identified in ∼25% of patients with multiple sclerosis (MS), it has yet to be investigated in patients at an earlier disease stage, namely clinical
Autor:
Graziela Cerchiaro, Ilan S. Schwartz, Rachel Lim, Karla J Ryckborst, Breanne Stewart, Bijoy K. Menon, Carol Kenney, Vikram Karnik, Maryna Yaskina, Kwadwo Mponponsuo, Mari E. Boesen, Craig Doram, Scott Jamieson, Michael D. Hill, Luanne Metz, Brett D Edwards, Lawrence Richer, Jamie Greenfield, Aravind Ganesh, Sarah Rathwell
Publikováno v:
CMAJ Open
Background Identification of therapies to prevent severe COVID-19 remains a priority. We sought to determine whether hydroxychloroquine treatment for outpatients with SARS-CoV-2 infection could prevent hospitalization, mechanical ventilation or death
Autor:
Monika Ashwin, Tanya Kuper, Tanya Narang, Yanhong Li, Syed Ibrahim, S. Joseph Kim, Olusegun Famure, Jamie Greenfield
Publikováno v:
Progress in transplantation (Aliso Viejo, Calif.). 31(4)
Introduction: Proteinuria is recognized as an independent risk factor for cardiovascular disease in kidney transplant recipients, but previous studies have not considered the impact of changes in urine protein over time. Research Question and Design:
Autor:
Anthony Traboulsee, Jamie Greenfield, Maryam Nakhaei-Nejad, Carlos R Camara-Lemarroy, Luanne M. Metz, Chieh-Hsin Lee, Reza Dowlatabadi, Fabrizio Giuliani, David K.B. Li, Hans J. Vogel, Graziela Cerchiaro, V. Wee Yong, Claudia Silva
Publikováno v:
Multiple sclerosis and related disorders. 50
Background Increasing evidence suggests that various inflammatory, immunological and metabolic pathways are altered in the clinically isolated syndrome (CIS) of multiple sclerosis (MS). Moreover, recent diagnostic criteria have made possible the very
Publikováno v:
Journal of neurology. 267(9)
Epidemiological, pathological and radiological studies suggest that inflammatory demyelination in MS is an age-dependent process, and that the formation of focal inflammatory demyelinating lesions decreases with age. Gadolinium-enhancing lesions are
Autor:
Nathalie Jette, Ruth Ann Marrie, Kirsten M. Fiest, Luanne M. Metz, Scott B. Patten, Jamie Greenfield
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-9 (2017)
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes
Background Though many people with multiple sclerosis (MS) have comorbidities, the use of generic and disease-specific health related quality of life (HRQOL) scales to discriminate the effects of comorbidity has not been established. The utility of t